Phase 2 Clinical Trial of Simultaneous Boost Intensity Modulated Radiation Therapy With 3 Dose Gradients in Patients With Stage I-II Nasal Type Natural Killer/T-Cell Lymphoma: Long-Term Outcomes of Survival and Quality of Life
- Resource Type
- Article
- Source
- In
International Journal of Radiation Oncology, Biology, Physics 1 March 2024 118(3):770-780 - Subject
- Language
- ISSN
- 0360-3016